Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP374624.RAR2BkvxxXg-gH1quqOLZaB6_IVcBT2h1govAeSLKQJEc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP374624.RAR2BkvxxXg-gH1quqOLZaB6_IVcBT2h1govAeSLKQJEc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP374624.RAR2BkvxxXg-gH1quqOLZaB6_IVcBT2h1govAeSLKQJEc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP374624.RAR2BkvxxXg-gH1quqOLZaB6_IVcBT2h1govAeSLKQJEc130_provenance.
- NP374624.RAR2BkvxxXg-gH1quqOLZaB6_IVcBT2h1govAeSLKQJEc130_assertion description "[More significantly, the combination of intravenously administered ligand-liposome-AS HER-2 ODN and docetaxel resulted in a marked inhibition of xenograft growth in an aggressive breast cancer model that does not overexpress HER-2, even after treatment ended.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374624.RAR2BkvxxXg-gH1quqOLZaB6_IVcBT2h1govAeSLKQJEc130_provenance.
- NP374624.RAR2BkvxxXg-gH1quqOLZaB6_IVcBT2h1govAeSLKQJEc130_assertion evidence source_evidence_literature NP374624.RAR2BkvxxXg-gH1quqOLZaB6_IVcBT2h1govAeSLKQJEc130_provenance.
- NP374624.RAR2BkvxxXg-gH1quqOLZaB6_IVcBT2h1govAeSLKQJEc130_assertion SIO_000772 12435858 NP374624.RAR2BkvxxXg-gH1quqOLZaB6_IVcBT2h1govAeSLKQJEc130_provenance.
- NP374624.RAR2BkvxxXg-gH1quqOLZaB6_IVcBT2h1govAeSLKQJEc130_assertion wasDerivedFrom befree-2016 NP374624.RAR2BkvxxXg-gH1quqOLZaB6_IVcBT2h1govAeSLKQJEc130_provenance.
- NP374624.RAR2BkvxxXg-gH1quqOLZaB6_IVcBT2h1govAeSLKQJEc130_assertion wasGeneratedBy ECO_0000203 NP374624.RAR2BkvxxXg-gH1quqOLZaB6_IVcBT2h1govAeSLKQJEc130_provenance.
- befree-2016 importedOn "2016-02-19" NP374624.RAR2BkvxxXg-gH1quqOLZaB6_IVcBT2h1govAeSLKQJEc130_provenance.